H.C. Wainwright raised the firm's price target on Microvast to $6 from $3 and keeps a Buy rating on the shares. The firm cites strength in the company's operating performance and higher confidence on the completion of Huzhou 3.2 expansion by Q4 for the target increase. This latter will add two gigawatt-hour of annual production capacity to Microvast's support growth expectations in 2026 and beyond, the analyst tells investors in a research note.
